NovastraList holds 10.46% of Jin Medical

Jin Medical International Ltd. (ZJYL) reports that NovastraList Horizon LTD and its sole owner, Chang Gil LEE, beneficially own 7,702,376 Class A ordinary shares.

Rhea-AI Filing Summary

Jin Medical International Ltd. (ZJYL) reports that NovastraList Horizon LTD and its sole owner, Chang Gil LEE, beneficially own 7,702,376 Class A ordinary shares. This represents 10.46% of Jin Medical’s Class A ordinary shares, based on 73,663,428 shares outstanding as of July 28, 2026.

NovastraList Horizon LTD holds these shares directly, with sole voting and dispositive power over all 7,702,376 shares. As the 100% owner and sole director of NovastraList Horizon LTD, Chang Gil LEE may be deemed to indirectly beneficially own the same shares, and he has sole voting and dispositive power over them through the entity, while disclaiming beneficial ownership beyond his pecuniary interest.

Key Figures

Beneficially owned shares: 7,702,376 Class A Ordinary Shares Ownership percentage: 10.46% Shares outstanding: 73,663,428 Class A ordinary shares +3 more

6 metrics

Beneficially owned shares 7,702,376 Class A Ordinary Shares Class A ordinary shares of Jin Medical International Ltd. beneficially owned by NovastraList Horizon LTD and Chang Gil LEE

Ownership percentage 10.46% Percent of Jin Medical’s Class A ordinary shares owned by NovastraList Horizon LTD and Chang Gil LEE

Shares outstanding 73,663,428 Class A ordinary shares Total Class A ordinary shares outstanding as of July 28, 2026, used to calculate ownership percentage

Par value per share US$0.001 per share Par value of Jin Medical International Ltd. Class A Ordinary Shares

Sole voting power 7,702,376 shares Shares over which NovastraList Horizon LTD and Chang Gil LEE have sole power to vote

Sole dispositive power 7,702,376 shares Shares over which NovastraList Horizon LTD and Chang Gil LEE have sole power to dispose

Key Terms

beneficially own, sole voting power, sole dispositive power, Class A Ordinary Shares, +1 more

5 terms

beneficially own financial

"Accordingly, Chang Gil LEE may be deemed to indirectly beneficially own the Class A ordinary shares"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

sole voting power financial

"Sole Voting Power 7,702,376.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 7,702,376.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Class A Ordinary Shares financial

"Title of class of securities: Class A Ordinary Shares, par value US$0.001 per share"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

Schedule 13G regulatory

"Form type: SCHEDULE 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Jin Medical International Ltd. (ZJYL) shares does NovastraList Horizon LTD own?

NovastraList Horizon LTD beneficially owns 7,702,376 Class A ordinary shares of Jin Medical International Ltd. These shares are held directly by NovastraList Horizon LTD and represent a significant minority stake in the company’s Class A ordinary share class.

What percentage of Jin Medical (ZJYL) does NovastraList Horizon LTD and Chang Gil LEE own?

NovastraList Horizon LTD and Chang Gil LEE together report beneficial ownership of 10.46% of Jin Medical’s Class A ordinary shares. This percentage is calculated using 73,663,428 Class A shares outstanding as of July 28, 2026, as provided by the company.

Who controls the Jin Medical (ZJYL) shares held by NovastraList Horizon LTD?

Chang Gil LEE controls the shares held by NovastraList Horizon LTD. He is the sole director and 100% owner of NovastraList Horizon LTD and has sole voting and dispositive power over the 7,702,376 Class A ordinary shares held by the entity.

Does Chang Gil LEE directly or indirectly own Jin Medical (ZJYL) shares?

The Class A ordinary shares are directly held by NovastraList Horizon LTD. As sole shareholder of that entity, Chang Gil LEE may be deemed to indirectly beneficially own those shares through NovastraList Horizon LTD, subject to his pecuniary interest.

What is the share class reported in this Jin Medical (ZJYL) Schedule 13G?

The filing covers Class A Ordinary Shares of Jin Medical International Ltd., each with a par value of US$0.001 per share. The reported beneficial ownership and percentage relate specifically to this Class A ordinary share class.

As of what date is the Jin Medical (ZJYL) ownership percentage calculated?

The 10.46% ownership stake is calculated based on 73,663,428 Class A ordinary shares outstanding as of July 28, 2026. This outstanding share figure was provided by Jin Medical International Ltd. and is the basis for the percentage calculation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:31 PM EDT Accepted by SEC EDGAR 08/18/2026 - 04:30 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Jin Medical International Ltd.

(Name of Issuer)

Class A Ordinary Shares, par value US$0.001 per share

(Title of Class of Securities)

G5140V120

(CUSIP Number)

08/18/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G5140V120

1

Names of Reporting Persons

NOVASTRALIST HORIZON LTD.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

VIRGIN ISLANDS, BRITISH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,702,376.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,702,376.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,702,376.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.46 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: The numbers in Rows 5, 7, and 9 consist of 7,702,376 Class A ordinary shares of JIN MEDICAL INTERNATIONAL LTD. (the "Issuer") held by NovastraList Horizon LTD. The percentage in Row 11 is calculated based on a total of 73,663,428 Class A ordinary shares outstanding as of July 28, 2026, as provided by the Issuer. Chang Gil LEE is the sole director and 100% owner of NovastraList Horizon LTD. and exercises voting and dispositive power over the Class A Ordinary Shares held by NovastraList Horizon LTD.

SCHEDULE 13G

CUSIP Number(s): G5140V120

1

Names of Reporting Persons

Chang Gil LEE

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

KOREA, REPUBLIC OF

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,702,376.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,702,376.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,702,376.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.46 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The numbers in Rows 5, 7, and 9 consist of 7,702,376 Class A ordinary shares of JIN MEDICAL INTERNATIONAL LTD. (the "Issuer") held by NovastraList Horizon LTD. The percentage in Row 11 is calculated based on a total of 73,663,428 Class A ordinary shares outstanding as of July 28, 2026, as provided by the Issuer. Chang Gil LEE is the sole director and 100% owner of NovastraList Horizon LTD. Chang Gil LEE has dispositive and voting power with respect to, and as such, may be deemed to be the beneficial owner of the securities held by NovastraList Horizon LTD.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Jin Medical International Ltd.
(b)	Address of issuer's principal executive offices: No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, 213149, People's Republic of China
Item 2.
(a)	Name of person filing: NovastraList Horizon LTD. Chang Gil LEE The Class A ordinary shares reported herein are directly held by NovastraList Horizon LTD. Chang Gil LEE is the sole shareholder of NovastraList Horizon LTD. Accordingly, Chang Gil LEE may be deemed to indirectly beneficially own the Class A ordinary shares of the Issuer held by NovastraList Horizon LTD. Chang Gil LEEdisclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly
(b)	Address or principal business office or, if none, residence: NovastraList Horizon LTD. : 410, YK First Tower, 565 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Korea, Republic of Chang Gil LEE: 410, YK First Tower, 565 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Korea, Republic of
(c)	Citizenship: NovastraList Horizon LTD.: British Virgin Islands Chang Gil LEE: South Korea
(d)	Title of class of securities: Class A Ordinary Shares, par value US$0.001 per share
(e)	CUSIP Number(s): G5140V120
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 7,702,376 Class A Ordinary Shares
(b)	Percent of class: 10.46%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 7,702,376 Class A Ordinary Shares
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 7,702,376 Class A Ordinary Shares
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NOVASTRALIST HORIZON LTD.

Signature:	/s/ Chang Gil LEE
Name/Title:	Chang Gil LEE, Director of NovastraList Horizon LTD.
Date:	08/18/2026

Chang Gil LEE

Signature:	/s/ Chang Gil LEE
Name/Title:	Chang Gil LEE
Date:	08/18/2026

Exhibit Information

99.1 Joint Filing Agreement